Samyang Biopharm Corporation (0120G0) Price & Analysis

― Followers

0120G0 Stock Chart & Stats

₩38500.00

₩4,600.00(13.57%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range₩23,250.00 - ₩150,900.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)23.13K

Market Cap

₩251.88B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.05

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding7,435,870

10 Day Avg. Volume19,019

30 Day Avg. Volume23,131

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

0120G0 FAQ

What was Samyang Biopharm Corporation’s price range in the past 12 months?

Samyang Biopharm Corporation lowest stock price was ₩23250.00 and its highest was ₩150900.00 in the past 12 months.

What is Samyang Biopharm Corporation’s market cap?

Samyang Biopharm Corporation’s market cap is ₩251.88B.

When is Samyang Biopharm Corporation’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Samyang Biopharm Corporation’s earnings last quarter?

Samyang Biopharm Corporation released its earnings results on May 15, 2026. The company reported ₩345.431 earnings per share for the quarter, beating the consensus estimate of N/A by ₩345.431.

Is Samyang Biopharm Corporation overvalued?

According to Wall Street analysts Samyang Biopharm Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Samyang Biopharm Corporation pay dividends?

Samyang Biopharm Corporation does not currently pay dividends.

What is Samyang Biopharm Corporation’s EPS estimate?

Samyang Biopharm Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Samyang Biopharm Corporation have?

Samyang Biopharm Corporation has 7,435,870 shares outstanding.

What happened to Samyang Biopharm Corporation’s price movement after its last earnings report?

Samyang Biopharm Corporation reported an EPS of ₩345.431 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.665%.

Which hedge fund is a major shareholder of Samyang Biopharm Corporation?

Currently, no hedge funds are holding shares in KR:0120G0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology